Italy starts testing potential Covid-19 vaccine on healthy volunteers
Italy has started human trials of a potential Covid-19 vaccine as part of the global...
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab...
FibroGen starts enrolment in pamrevlumab trial for Covid-19
FibroGen has started patient enrolment for a Phase II/III clinical trial of pamrevlumab for the...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
EUSA Pharma reports data of siltuximab in coronavirus trial
EUSA Pharma has reported preliminary results from the SISCO study of siltuximab for the treatment...
Coronavirus in Italy: Outbreak, measures and impact
Italy, a member state of the European Union and a popular tourist destination, joined the...
Lamzede (velmanase alfa) to Treat Alpha-Mannosidosis
Lamzede® (velmanase alfa) is one of the first enzyme replacement therapies indicated for the treatment...
Researchers report positive data from trial of breast cancer drug
A joint research team from the University of Pisa in Italy and the UK's University...
Deals this week: Immutep, Enesi Pharma, LineaRx
Australian biotechnology company Immutep has entered a clinical trial collaboration agreement with Merck and Pfizer...
Deals and M&As this week: Pliant Therapeutics, MolMed, Modus Therapeutics
Pliant Therapeutics has raised $62m through a series B financing round from Cowen Healthcare Investments.